Home » Topics » Regulatory

Regulatory
RSS

Raptiva approved for chronic, moderate to severe plaque psoriasis

Oct. 30, 2003

Levaquin approved for five-day treatment of CAP

Oct. 30, 2003

Cyberonics submits PMA-S for VNS Therapy

Oct. 29, 2003

Remicade approved in E.U. for maintenance dosing in fistulizing Crohn's disease

Oct. 27, 2003

Starlix approved in combination with TZD for type 2 diabetes

Oct. 27, 2003

Approvable letter issued for Foradil Certihaler

Oct. 24, 2003

Approvable letter issued for expansion of Provigil labeling

Oct. 23, 2003

Once-weekly Enbrel approved

Oct. 23, 2003

Lexiva, the only protease inhibitor offering flexible dosing, approved in U.S.

Oct. 22, 2003

Paxil CR approved for social anxiety disorder

Oct. 22, 2003

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...